BOTHELL, WA - August 17, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced that on August 14, 2009, it completed the acquisition of CardioDynamics International Corporation (Nasdaq:CDIC), a leader in impedance cardiography (ICG) for noninvasive hemodynamic assessment. Under the terms of the agreement, CardioDynamics will become a wholly-owned subsidiary of Sonosite, Inc. and CardioDynamics shareholders will receive $1.35 per share in cash. The aggregate transaction is valued at approximately $10.0 million, or $12.3 million net of cash and debt.
Shareholders of CardioDynamics approved the acquisition on August 11, 2009. "This acquisition brings us an established sales channel and a franchise in cardiovascular disease management with outstanding long term growth and healthcare cost reduction potential," said Kevin M. Goodwin, Sonosite President and CEO.
"The need to detect and treat cardiovascular disease has never been greater, and CardioDynamics' products and technology will be the platform we will build upon to grow in the physician office segment, as well as expand our presence in the large market for cardiovascular disease management." "Both Sonosite and CardioDynamics have a rich history of innovation and market development," said Marcus Smith, Sonosite Vice President, General Manager, Cardiovascular Disease Management.… [Read more]
Medicine's new wave
ZotZine | November, 2010
"On her first day as a UC Irvine medical student, Sarah Rooney received an Apple iPad."
This Fox Hunts with Ultrasound
New University | November 30, 2010
"This school year, UC Irvine has become one of the first medical schools in the nation to integrate portable ultrasound training into its curriculum."
New ultrasound technology sharpens needle visibility
DotMed Business News | November 2010
"Ultrasound is widely used to guide needles as they advance through tissue to their targets.… [Read more]
BOTHELL, WA - September 10, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced the appointment of John S. Bowers, Jr. as Senior Vice President of Strategic Development and Patient Safety Innovations. Mr. Bowers brings a depth of experience to Sonosite. With more than 20 years in the medical technology industry, he has held a number of general management, business development and sales management leadership roles. Most recently, Mr. Bowers served as the President and CEO of Northstar Neuroscience, Inc., a publicly traded medical device company specializing in the development of treatments for neurological diseases and disorders. Prior to Northstar, he spent 14 years at Guidant Corporation and Eli Lilly in management positions of increasing responsibility.… [Read more]
BOTHELL, WA - September 14, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, announced today new patient safety technology and mobile power solutions for vascular access applications. The company will be showcasing the new products and capabilities at the annual scientific meeting of the Association for Vascular Access (AVA) being held in Las Vegas September 14th - 18th, 2009.
The Nanomaxx™ Ultrasound System
Sonosite will be showing the 6-pound NanoMaxx ultrasound tool1, the latest addition to its suite of specialized products for point-of-care visualization in medicine. Combining one-button optimization technology with a fluid resistant touch screen user interface, the NanoMaxx system is highly sophisticated, easy to use and easy to disinfect. While other touch screens require a stylet to activate system controls, the sensitivity of the NanoMaxx touch screen allows the user to operate the system with the touch of a finger while wearing sterile gloves. The image quality and color flow mapping on the NanoMaxx provide increased utility versus alternatives by giving users the ability to identify nerve bundles and distinguish veins from arteries, delivering the visualization needed for safe and effective line placements.
1Availability in the US pending FDA 510(k) clearance.… [Read more]
BOTHELL, WA - September 17, 2009 - Sonosite, Inc. (Nasdaq: SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, said today that Kevin M. Goodwin, President and CEO, will present at the UBS Global Life Sciences Conference being held at the Grand Hyatt Hotel in New York City, September 21 - 23, 2009. Mr. Goodwin's presentation will be webcast live on September 23, 2009 at 8:30 am Eastern Time. An audio replay will be available for 30 days following and can be accessed via Sonosite’s website at http://www.sonosite.com/investorinformation/webcasts/.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 750
people worldwide.… [Read more]
BOTHELL, WA - September 22, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound at the point-of-care announced today the launch of its new corporate website (www.sonosite.com). The new site incorporates a sleek new look with intuitive navigation and more robust content. It includes an abundant amount of educational information to provide healthcare professionals with the support they need to effectively use their Sonosite products, as well as assist medical professionals searching for hand-carried and mountable ultrasound systems.
"Sonosite hand-carried and mountable products have revolutionized patient safety, quality and cost of care in medicine by enabling simple and efficient ultrasound visualization at the point-of-care," said Kevin M. Goodwin, Sonosite President and CEO. "We know and respect that time is critical for medical professionals, so we have streamlined our website's navigation process. Users can access digital content quickly and efficiently. Health care consumers and other visitors to the website will also find relevant information about our company and how point-of-care ultrasound is improving patient safety, quality and cost in medical delivery." In the new website, Sonosite has greatly expanded the… [Read more]
BOTHELL, WA–October 5, 2009–Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, announced today Sonosite® Mobile Solutions, for cordless charging and extended battery life of its ultrasound systems.
Sonosite’s PowerPort allows cordless charging of the Sonosite system when it is mounted or docked in the Universal Stand. Parking the stand on the PowerPort eliminates the need to find an electrical outlet and provides a designated station for the stand and system. Sonosite’s PowerPack triples battery life and can keep a system charged for 6 hours or more allowing clinicians the flexibility needed to see more patients on a single charge. The PowerPack is easily installed on the column of Sonosite’s Universal Stand.
Sonosite also announced its new ergonomic Universal Stands for added versatility and increased mobility. Compatible with the M-Turbo®, S Series™, NanoMaxx™1 and MicroMaxx® product lines, Sonosite’s Universal Stands are light, easy to customize with accessories, highly maneuverable in the hospital setting and easily positioned by the patient bedside or in other space-constrained areas.
Customer deliveries are expected to begin at the end of the fourth quarter 2009.
1 Availability in the US pending FDA 510(k) clearance.… [Read more]
Company now shipping the breakthrough NanoMaxx™ system to US customers
BOTHELL, WA - October 5, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that the company has received FDA 510(k) clearance for its new NanoMaxx™ ultrasound system and is commencing US customer deliveries. International deliveries began at the end of June.
Based on Sonosite’s 4th generation Turbo technology, the six pound NanoMaxx system is the latest addition to Sonosite’s suite of specialized products for point-of-care visualization in medicine. Complete with streamlined one button optimization technology, a touch screen user interface and Sonosite’s industry-leading 5-year warranty, the NanoMaxx system is ideal for both hospital and office markets and designed to provide healthcare professionals with improved patient safety practices, expanded workflow capabilities and exam room flexibility.… [Read more]
BOTHELL, WA - October 14, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for point-of-care medicine, said today that it will report the company’s third quarter financial results on Tuesday, October 27, 2009 at the close of market and host a conference call at 1:30 pm PT/4:30 ET. The call will be broadcast live and can be accessed via Sonosite’s website at www.sonosite.com/investorinformation/webcasts.
A replay of the audio webcast will be available beginning October 27, 2009, 5:30 pm PT and will be available until November 10, 2009, 9:59 pm PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 1942151 is required to access the replay. The call will also be archived on Sonosite’s website.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.… [Read more]
New System, New Workflow Solutions and New Mobile Power Solutions
BOTHELL, WA – October 16, 2009 – Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced that the new, 6 pound NanoMaxx™ ultrasound system will be making its debut, along with its workflow and mobile power solutions during the American Society of Anesthesiologists 2009 Annual Meeting. The conference is being held in New Orleans at the Ernest N. Morial Convention Center, October 18-20th.
The NanoMaxx Ultrasound Tool… [Read more]
Thousands of Physicians Worldwide are Benefitting from SonoAccess BOTHELL, WA - November 9, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for point-of-care medicine, today announced the expansion of the SonoAccess™ iPhone® application to include musculoskeletal specialties. SonoAccess is the first iPhone application to provide physicians with a comprehensive multimedia database of ultrasound resource materials.
Dedicated to providing innovative educational tools to musculoskeletal physicians, the SonoAccess app is customized for rheumatologists, orthopedic surgeons, physiatrists and sports medicine physicians. Partnering with leading physicians and educators within the ultrasound community, Sonosite has created a comprehensive library of scanning technique videos with case studies and an expansive image gallery to meet the needs of musculoskeletal physicians.… [Read more]
Industry leaders, Decision Makers and Customers Gathered in Europe to Experience the Latest Technology for Patient Safety
BOTHELL, WA - December 7, 2009 – Sonosite Inc., the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that the company has completed the launch of the 6 pound NanoMaxx™ ultrasound tool in Europe. The latest system to join Sonosite’s suite of specialized products for point-of-care visualization, the NanoMaxx system made its debut during fall exhibitions, road shows and key events hosted in France, Germany, Italy, Spain, UK and a number of other countries. Sonosite hosted various events to introduce the NanoMaxx system. At these gatherings, physicians from multiple medical specialties participated in a day of clinical education and hands on scanning led by key opinion leaders in the industry.
“This was a great opportunity for physicians to learn more about the NanoMaxx system and to be educated on the latest ultrasound practices, especially with risk management and patient safety practices becoming more stringent in the hospital setting,” said Mike Fernandez, Sonosite, General Manager, Europe and Latin America. “With the ability to expedite workflow, guide interventional procedures and provide visualization and diagnostics at any point-of-care location, the NanoMaxx system is truly a powerful tool that will raise the standard of healthcare practices around the globe.”… [Read more]
BOTHELL, WA – December 28, 2009 – Sonosite, Inc. (Nasdaq: SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that Kevin M. Goodwin, President and CEO, will present at the 28th Annual J.P. Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco, January 11-14, 2010. Mr. Goodwin’s presentation will be webcast live on January 12, 2010 beginning at 10:30 a.m. Pacific Time. An audio replay will be available for 30 days following and can be accessed via Sonosite’s website at www.sonosite.com/investorinformation/webcasts.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.… [Read more]
BOTHELL, WA – January 5, 2010 – Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today provided preliminary revenue results for the fourth quarter and year ended December 31, 2009. Overall 2009 revenue was approximately $69 million in the fourth quarter and $227 million for the year. Overall revenue included $4 million for the fourth quarter and $7 million for the year from the recently acquired CardioDynamics International Corporation (CDIC). Excluding CDIC, revenue was down 7% in the fourth quarter and down 10% for the year compared to the prior year.
For the quarter, a decrease in military orders caused a 6% revenue decline. Changes in foreign currency rates increased revenue in the fourth quarter by 4% but decreased revenue by 2% for the year. “Exiting 2009, we were encouraged by an uptick in momentum during the fourth quarter,” said Kevin Goodwin, Sonosite President and CEO. “On a constant currency basis, international revenue was level in the fourth quarter and grew 1% for the year. Our US Direct business was down compared to the prior year but continued to grow sequentially. Strong US bookings at the year end and a positive outlook by our sales force have provided some renewed optimism heading into 2010.” The revenue estimates are preliminary. Sonosite plans to report complete fourth quarter and 2009 financial results on February 11, 2010 after the close of the financial markets.
Conference Call Information… [Read more]
BOTHELL, WA – January 11, 2010 – Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced that its Board of Directors has authorized Sonosite to repurchase up to $150 million of the Company’s common stock or outstanding convertible notes for cash. In connection with the repurchase authorization, the company will purchase up to $100 million of the Company’s common stock through a modified “Dutch Auction” tender offer.
Sonosite intends to commence the tender offer during the week of January 18, 2010. Under the terms of the proposed tender offer, Sonosite shareholders will have the opportunity to tender some or all of their shares at a price within the range of $26.10 to $30.00 per share. Based on the number of shares tendered and the prices specified by the tendering shareholders, Sonosite will determine the lowest per share price within the range that will enable it to buy $100 million in shares, or such lesser number of shares that are properly tendered.… [Read more]
BOTHELL, WA – January 19, 2010 – Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced the commencement of its previously announced tender offer to repurchase up to $100 million of the Company's common stock for cash through a modified "Dutch Auction" tender offer. As previously announced, under the terms of the tender offer, Sonosite shareholders have the opportunity to tender some or all of their shares at a price within the range of $26.10 to $30.00 per share.
Based on the number of shares tendered and the prices specified by the tendering shareholders, Sonosite will determine the lowest per share price within the range that will enable it to buy $100 million in shares, or such lesser number of shares that are properly tendered. All shares accepted for payment will be paid the same price, regardless of whether a shareholder tendered such shares at a lower price within the range. At the minimum price of $26.10 per share, Sonosite would repurchase a maximum of 3,831,417 shares, which represents approximately 22% of Sonosite's currently outstanding common stock.… [Read more]
BOTHELL, WA – January 21, 2010 – Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, said today that it will report the company’s fourth quarter financial results on Thursday, February 11, 2010 at the close of market and will host a conference call at 1:30 p.m. PT/4:30 p.m. ET.
The call will be broadcast live and can be accessed via Sonosite’s website at www.sonosite.com/investorinformation/webcasts. A replay of the audio webcast will be available beginning February 11, 2010 at 5:30 p.m. PT and can be accessed until February 25, 2010 at 9:59 p.m. PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7406921 is required to access the replay. Additionally, the call will be archived on Sonosite’s website.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.… [Read more]
Q4 2009 Operating Income Grows 117% as Operating Margins Hit 15.4% Excluding Non-recurring Items Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern
BOTHELL, WA - February 11, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today reported financial results for the fourth quarter and year ended December 31, 2009.
REVENUE
Revenues in the fourth quarter of 2009 were $69.7 million, a decrease of 1% compared to the fourth quarter of 2008. Full year of 2009 revenues were $227.4 million, down 7% versus full year of 2008. Revenues for the partial year acquisition of CardioDynamics were $4.2 million for the fourth quarter and $7.1 million for the full year of 2009. Excluding partial year revenues from CDIC, Sonosite fourth quarter revenues were $65.5 million, down 7% versus the fourth quarter of 2008. Full year revenues excluding CDIC were $220.3 million, a decrease of 10% compared to 2008. Changes in foreign currency rates increased worldwide revenues by 4% in the fourth quarter and decreased revenues by 2% for the full year.
OPERATING INCOME AND CASH FLOW Fourth Quarter Results… [Read more]
BOTHELL, WA - February 22, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced the preliminary results of its modified "Dutch Auction" tender offer which expired at 5:00 p.m. New York City time on February 19, 2010.
Based on the preliminary analysis by the depositary, an aggregate of 2,973,050 shares were properly tendered and not withdrawn, including approximately 1,073,209 shares that were tendered through notice of guaranteed delivery, at prices at or below $30.00. Accordingly, pursuant to the terms of the Offer to Purchase, the Letter of Transmittal and applicable securities laws, Sonosite expects to accept for payment up to an aggregate of 2,973,050 shares of its common stock at a purchase price of $30.00 per share.
The tender offer was made pursuant to an Offer to Purchase and Letter of Transmittal, each dated January 19, 2010, filed with the Securities and Exchange Commission on January 10, 2010, as amended on January 28, 2010 and February 16, 2010.
The Dealer Manager for the tender offer was J.P. Morgan Securities, Inc. and the Information Agent was Georgeson Inc.
The number of shares to be purchased in the tender offer and the price per share are preliminary. The determination of the final number of shares to be purchased is subject to confirmation by the depositary of the proper delivery of the shares properly tendered and not withdrawn.… [Read more]